We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
(+19%)
Cap. Flow
+$417M
Cap. Flow
% of AUM
8.07%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$43.8M |
| 2 |
Gilead Sciences
GILD
|
+$40.8M |
| 3 |
GE Aerospace
GE
|
+$37.3M |
| 4 |
Motorola Solutions
MSI
|
+$24.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$53.2M |
| 2 |
Amgen
AMGN
|
+$30.4M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$21.5M |
| 4 |
Canadian National Railway
CNI
|
+$20.9M |
| 5 |
Becton Dickinson
BDX
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.91% |
| 4 | Communication Services | 9.31% |
| 5 | Industrials | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTD
576
DELISTED
TD Ameritrade Holding Corp
AMTD
| $825K | 0.02% |
+21,220
| New | +$904K |
|
577
Fluor
FLR
$7.29B
| $824K | 0.02% |
15,666
+4,209
| +37% | +$230K |
|
|
CTRA
578
DELISTED
Coterra Energy
CTRA
| $812K | 0.02% |
33,960
-341,946
| -91% | -$7.76M |
|
579
Howmet Aerospace
HWM
$116B
| $810K | 0.02% |
40,111
-20,777
| -34% | -$408K |
|
580
Hilton Worldwide
HLT
$74B
| $804K | 0.02% |
+13,755
| New | +$799K |
|
581
Cheniere Energy
LNG
$56.5B
| $792K | 0.02% |
16,747
+4,165
| +33% | +$192K |
|
582
United Rentals
URI
$71.1B
| $791K | 0.02% |
+6,327
| New | +$770K |
|
|
VER
583
DELISTED
VEREIT, Inc.
VER
| $787K | 0.02% |
18,541
+3,059
| +20% | +$132K |
|
584
Bath & Body Works
BBWI
$4.01B
| $786K | 0.02% |
20,638
-14,808
| -42% | -$668K |
|
585
The Mosaic Company
MOS
$7.09B
| $783K | 0.02% |
26,816
+6,364
| +31% | +$196K |
|
586
Targa Resources
TRGP
$60.4B
| $783K | 0.02% |
13,067
+3,410
| +35% | +$198K |
|
587
Global Payments
GPN
$22.1B
| $778K | 0.02% |
9,645
+2,597
| +37% | +$204K |
|
|
CA
588
DELISTED
CA, Inc.
CA
| $752K | 0.01% |
23,718
+3,328
| +16% | +$107K |
|
589
Chipotle Mexican Grill
CMG
$40.8B
| $739K | 0.01% |
82,950
+20,200
| +32% | +$167K |
|
590
Ally Financial
ALLY
$13.1B
| $736K | 0.01% |
36,193
+6,552
| +22% | +$139K |
|
|
ANSS
591
DELISTED
Ansys
ANSS
| $734K | 0.01% |
6,865
+1,943
| +39% | +$195K |
|
592
Verisk Analytics
VRSK
$26.4B
| $732K | 0.01% |
9,023
+1,118
| +14% | +$91.8K |
|
593
Bunge Global
BG
$23.6B
| $724K | 0.01% |
9,133
+1,495
| +20% | +$112K |
|
|
WFM
594
DELISTED
Whole Foods Market Inc
WFM
| $719K | 0.01% |
24,184
+5,098
| +27% | +$153K |
|
|
CDK
595
DELISTED
CDK Global, Inc.
CDK
| $687K | 0.01% |
10,560
-70
| -0.7% | -$4.48K |
|
|
RDHL
596
Redhill Biopharma
RDHL
$3.85M
| $683K | 0.01% |
71
| – | – |
|
|
PX
597
DELISTED
Praxair Inc
PX
| $682K | 0.01% |
5,747
-13,155
| -70% | -$1.55M |
|
|
XEC
598
DELISTED
CIMAREX ENERGY CO
XEC
| $679K | 0.01% |
5,679
+721
| +15% | +$93.5K |
|
|
TRIL
599
DELISTED
Trillium Therapeutics Inc.
TRIL
| $677K | 0.01% |
110,000
| – | – |
|
600
Fidelity National Financial
FNF
$13.9B
| $672K | 0.01% |
24,858
+5,698
| +30% | +$145K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2017 Portfolio in Review
As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.
- Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
- Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
- Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
- Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
- Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
- Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.
Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.